- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
6
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
6 companies
Standard Chemical & Pharmaceutical
Market Cap: NT$10.2b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$57.00
7D
10.7%
1Y
-8.7%
TTY Biopharm
Market Cap: NT$18.2b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$73.20
7D
9.3%
1Y
-5.1%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.9b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$88.10
7D
7.4%
1Y
7.4%
PharmaEngine
Market Cap: NT$12.5b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$87.10
7D
13.9%
1Y
-5.9%
YungShin Global Holding
Market Cap: NT$17.8b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$66.70
7D
23.1%
1Y
38.5%
Sinphar PharmaceuticalLtd
Market Cap: NT$5.6b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$30.95
7D
6.5%
1Y
-8.4%